Endologix Completes Patient Enrollment in the Ovation® LIFE (Least Invasive Fast-Track EVAR) Study
May 16, 2016 09:00 ET
|
Endologix
IRVINE, Calif., May 16, 2016 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today that it has completed patient...
Endologix Reports Results for the First Quarter 2016
May 09, 2016 16:05 ET
|
Endologix
IRVINE, Calif., May 09, 2016 (GLOBE NEWSWIRE) -- Endologix, Inc. (NASDAQ:ELGX), developer and marketer of innovative treatments for aortic disorders, today announced financial results for the...
Endologix to Participate in Two Investor Conferences in May
April 29, 2016 09:00 ET
|
Endologix
IRVINE, Calif., April 29, 2016 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today that John McDermott, Chief...
Positive Nellix Clinical Data from the ASCEND Study for the Treatment of Juxta and Pararenal AAA Presented at the 38th Annual Charing Cross Symposium
April 28, 2016 12:15 ET
|
Endologix
IRVINE, Calif., April 28, 2016 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today the first data presentation...
Positive Nellix Clinical Data from the Global Registry and Treatment of Iliac Aneurysm Studies Presented at the 38th Annual Charing Cross Symposium
April 27, 2016 11:00 ET
|
Endologix
IRVINE, Calif., April 27, 2016 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today the presentation of positive...
Endologix to Report First Quarter 2016 Financial Results on May 9, 2016
April 19, 2016 16:00 ET
|
Endologix
IRVINE, Calif., April 19, 2016 (GLOBE NEWSWIRE) -- Endologix, Inc. (NASDAQ:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today details relating to the...
Endologix Announces CE Mark for Next-Generation Nellix® EndoVascular Aneurysm Sealing System
April 11, 2016 14:25 ET
|
Endologix
IRVINE, Calif., April 11, 2016 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today achievement of CE...
Endologix Announces First Patients in Japan Treated With Nellix® EndoVascular Aneurysm Sealing System
March 08, 2016 09:00 ET
|
Endologix
IRVINE, Calif., March 08, 2016 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today that the first two patients...
Endologix Announces First U.S. Commercial Implant of AFX®2 Bifurcated Endograft System
February 29, 2016 09:00 ET
|
Endologix
IRVINE, Calif., Feb. 29, 2016 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today that the first U.S....
Endologix Reports Results for the Fourth Quarter and Full Year 2015
February 22, 2016 16:05 ET
|
Endologix
8% Constant Currency Revenue Growth for the Full Year 2015 2015 Nellix European Systems Increase 42% Over Prior Year Provides 2016 Financial Guidance for Combined Company...